Product Information
ISIBLOOM 28 DAY TABLET is a generic product labeled by Xiromed LLC, priced at $0.1353 per EA under NDC 70700011385. Its NADAC has been published 421 times since Sep 12, 2018.
FDA first approved this application on Aug 12, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Xiromed LLCNDC
70700011385
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA202789FDA Approved
8/12/2015
TE Code
AB
On Market Since
2/1/2018
Price Statistics
The NADAC for ISIBLOOM 28 DAY TABLET has been published 421 times since Sep 12, 2018, and over the history we have for it it has declined 65.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1353 per EA |
|---|---|
| All-time high | $0.3904 (Sep 12, 2018) |
| All-time low | $0.1111 (Nov 20, 2024) |
| 52-week high | $0.1544 |
| 52-week low | $0.1299 |
| Median price | $0.1754 |
| Average price | $0.2064 |
| Largest weekly change | -31.0% (Sep 23, 2020) |
| Weeks tracked | 421 |
| Tracking since | Sep 12, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
desogestrel and ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ISIBLOOM 28 DAY TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ISIBLOOM 28 DAY TABLET, manufactured by Xiromed LLC, is $0.1353 per EA (NDC 70700011385), effective Sep 30, 2026.
How has the price of ISIBLOOM 28 DAY TABLET changed over time?
Over the history we have for it, the NADAC for ISIBLOOM 28 DAY TABLET has declined 65.3%. It has been tracked across 421 weekly CMS publications since Sep 12, 2018.
What are the highest and lowest recorded NADAC prices for ISIBLOOM 28 DAY TABLET?
Since Sep 12, 2018, the NADAC for ISIBLOOM 28 DAY TABLET has ranged from a low of $0.1111 (Nov 20, 2024) to a high of $0.3904 (Sep 12, 2018), with a median of $0.1754 per EA.
Are there cheaper alternatives to ISIBLOOM 28 DAY TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ENSKYCE 28 TABLET, is $0.1217 per EA — about 10% below ISIBLOOM 28 DAY TABLET.
Who manufactures ISIBLOOM 28 DAY TABLET?
ISIBLOOM 28 DAY TABLET (NDC 70700011385) is labeled by Xiromed LLC, and CMS classifies it as a generic product.